promising therapeutic targets. In this study, we describe a new class of neurosteroid analogues which possess structural modifications in the steroid D-ring region. These analogues were tested on recombinant GluN1/GluN2B receptors to evaluate the structure–activity relationship. Our results demonstrate that there is a strong correlation between this new structural feature and the in vitro activity, as all
Ñ -甲基- d天门冬
氨酸受体(N
MDARs)是谷
氨酸门控离子通道,在兴奋性突触传递中起关键作用。但是,N
MDAR的过度激活可能导致兴奋性毒性细胞损伤/死亡,因此,它们在许多神经病理学疾病中发挥作用。已知N
MDAR的活性受多种变构调节剂(包括神经甾体)的影响,这反过来又使它们成为有希望的治疗靶标。在这项研究中,我们描述了一类新的类
固醇神经类似物,在类
固醇D环区域具有结构修饰。这些类似物在
重组GluN1 / GluN2B受体上进行了测试,以评估其结构与活性之间的关系。我们的结果表明,这种新的结构特征与体外活性之间存在很强的相关性,与已知的内源性神经甾体-
孕烯醇酮硫酸盐(IC 50 = 24.6μM)相比,有50个值在90 nM至5.4μM之间变化。